Neuroblastoma
Researchers from the International Neuroblastoma Risk Group (INRG) Task Force have made significant strides in advancing the understanding of neuroblastoma, a rare form of cancer. By sharing knowledge and harmonizing approaches, the INRG Task Force has achieved a remarkable level of progress in the field. The group's data-sharing
Neonatology
Research conducted at the University Hospital Rouen in France has revealed the differential uptake of [123I]-mIBG and [18F]-FDOPA in the follow-up of neonatal neuroblastoma cases. Single photon emission computed tomography (SPECT/CT) using meta-iodobenzylguanidine (mIBG) is currently recommended in pediatric clinical guidelines for assessing neuroblastoma, but [¹²³I]-mIBG
Neuroblastoma
Neuroblastoma is a common malignant tumor in children and adolescents, with significant health burdens, especially for those under 19 years. A new study assesses the global, regional, and national burden of neuroblastoma from 1990 to 2021, highlighting the need for precision medicine in high-income regions and improved healthcare infrastructure in
Higher education
A groundbreaking study recently published in the Pediatric Hematology Oncology Journal has revealed that multifocal primary neuroblastomas in the non-infantile age group have favourable biological features and a good outcome for young patients. The study highlights a case of a 3-year-old girl who presented with an abdominal mass and was
Cancer metastasis
Children in developing countries face a high burden of advanced and metastatic cancer, with limited access to palliative care services. A recent study from the Regional Cancer Center in Kerala, India, analyzed the palliative care requirements for children with metastatic neuroblastoma (NB) and evaluated the current palliative care services offered.
